292 related articles for article (PubMed ID: 29738414)
1. Estrogen-alone therapy and invasive breast cancer incidence by dose, formulation, and route of delivery: findings from the WHI observational study.
Shufelt C; Bairey Merz CN; Pettinger MB; Choi L; Chlebowski R; Crandall CJ; Liu S; Lane D; Prentice R; Manson JE;
Menopause; 2018 Sep; 25(9):985-991. PubMed ID: 29738414
[TBL] [Abstract][Full Text] [Related]
2. Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study.
Shufelt CL; Merz CN; Prentice RL; Pettinger MB; Rossouw JE; Aroda VR; Kaunitz AM; Lakshminarayan K; Martin LW; Phillips LS; Manson JE
Menopause; 2014 Mar; 21(3):260-6. PubMed ID: 24045672
[TBL] [Abstract][Full Text] [Related]
3. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.
Anderson GL; Limacher M; Assaf AR; Bassford T; Beresford SA; Black H; Bonds D; Brunner R; Brzyski R; Caan B; Chlebowski R; Curb D; Gass M; Hays J; Heiss G; Hendrix S; Howard BV; Hsia J; Hubbell A; Jackson R; Johnson KC; Judd H; Kotchen JM; Kuller L; LaCroix AZ; Lane D; Langer RD; Lasser N; Lewis CE; Manson J; Margolis K; Ockene J; O'Sullivan MJ; Phillips L; Prentice RL; Ritenbaugh C; Robbins J; Rossouw JE; Sarto G; Stefanick ML; Van Horn L; Wactawski-Wende J; Wallace R; Wassertheil-Smoller S;
JAMA; 2004 Apr; 291(14):1701-12. PubMed ID: 15082697
[TBL] [Abstract][Full Text] [Related]
4. Comparison of clinical outcomes among users of oral and transdermal estrogen therapy in the Women's Health Initiative Observational Study.
Crandall CJ; Hovey KM; Andrews C; Cauley JA; Stefanick M; Shufelt C; Prentice RL; Kaunitz AM; Eaton C; Wactawski-Wende J; Manson JE
Menopause; 2017 Oct; 24(10):1145-1153. PubMed ID: 28697036
[TBL] [Abstract][Full Text] [Related]
5. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.
Stefanick ML; Anderson GL; Margolis KL; Hendrix SL; Rodabough RJ; Paskett ED; Lane DS; Hubbell FA; Assaf AR; Sarto GE; Schenken RS; Yasmeen S; Lessin L; Chlebowski RT;
JAMA; 2006 Apr; 295(14):1647-57. PubMed ID: 16609086
[TBL] [Abstract][Full Text] [Related]
6. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial.
LaCroix AZ; Chlebowski RT; Manson JE; Aragaki AK; Johnson KC; Martin L; Margolis KL; Stefanick ML; Brzyski R; Curb JD; Howard BV; Lewis CE; Wactawski-Wende J;
JAMA; 2011 Apr; 305(13):1305-14. PubMed ID: 21467283
[TBL] [Abstract][Full Text] [Related]
7. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.
Chlebowski RT; Anderson GL; Aragaki AK; Manson JE; Stefanick ML; Pan K; Barrington W; Kuller LH; Simon MS; Lane D; Johnson KC; Rohan TE; Gass MLS; Cauley JA; Paskett ED; Sattari M; Prentice RL
JAMA; 2020 Jul; 324(4):369-380. PubMed ID: 32721007
[TBL] [Abstract][Full Text] [Related]
8. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.
Manson JE; Chlebowski RT; Stefanick ML; Aragaki AK; Rossouw JE; Prentice RL; Anderson G; Howard BV; Thomson CA; LaCroix AZ; Wactawski-Wende J; Jackson RD; Limacher M; Margolis KL; Wassertheil-Smoller S; Beresford SA; Cauley JA; Eaton CB; Gass M; Hsia J; Johnson KC; Kooperberg C; Kuller LH; Lewis CE; Liu S; Martin LW; Ockene JK; O'Sullivan MJ; Powell LH; Simon MS; Van Horn L; Vitolins MZ; Wallace RB
JAMA; 2013 Oct; 310(13):1353-68. PubMed ID: 24084921
[TBL] [Abstract][Full Text] [Related]
9. Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials.
Chlebowski RT; Rohan TE; Manson JE; Aragaki AK; Kaunitz A; Stefanick ML; Simon MS; Johnson KC; Wactawski-Wende J; O'Sullivan MJ; Adams-Campbell LL; Nassir R; Lessin LS; Prentice RL
JAMA Oncol; 2015 Jun; 1(3):296-305. PubMed ID: 26181174
[TBL] [Abstract][Full Text] [Related]
10. Combined conjugated esterified estrogen plus methyltestosterone supplementation and risk of breast cancer in postmenopausal women.
Kabat GC; Kamensky V; Heo M; Bea JW; Hou L; Lane DS; Liu S; Qi L; Simon MS; Wactawski-Wende J; Rohan TE
Maturitas; 2014 Sep; 79(1):70-6. PubMed ID: 25011395
[TBL] [Abstract][Full Text] [Related]
11. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
Shumaker SA; Legault C; Kuller L; Rapp SR; Thal L; Lane DS; Fillit H; Stefanick ML; Hendrix SL; Lewis CE; Masaki K; Coker LH;
JAMA; 2004 Jun; 291(24):2947-58. PubMed ID: 15213206
[TBL] [Abstract][Full Text] [Related]
12. Estrogen metabolism in menopausal hormone users in the women's health initiative observational study: Does it differ between estrogen plus progestin and estrogen alone?
Falk RT; Manson JE; Barnabei VM; Anderson GL; Brinton LA; Rohan TE; Cauley JA; Chen C; Coburn SB; Pfeiffer RM; Reding KW; Sarto GE; Wentzensen N; Chlebowski RT; Xu X; Trabert B
Int J Cancer; 2019 Feb; 144(4):730-740. PubMed ID: 30183089
[TBL] [Abstract][Full Text] [Related]
13. Effects of oral conjugated equine estrogens with or without medroxyprogesterone acetate on incident hypertension in the Women's Health Initiative hormone therapy trials.
Swica Y; Warren MP; Manson JE; Aragaki AK; Bassuk SS; Shimbo D; Kaunitz A; Rossouw J; Stefanick ML; Womack CR
Menopause; 2018 Jul; 25(7):753-761. PubMed ID: 29381666
[TBL] [Abstract][Full Text] [Related]
14. Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women's health initiative clinical trials.
Crandall CJ; Aragaki AK; Cauley JA; McTiernan A; Manson JE; Anderson G; Chlebowski RT
Breast Cancer Res Treat; 2012 Feb; 132(1):275-85. PubMed ID: 22042371
[TBL] [Abstract][Full Text] [Related]
15. Effects of different hormone therapies on breast pain in recently postmenopausal women: findings from the Mayo Clinic KEEPS breast pain ancillary study.
Files JA; Miller VM; Cha SS; Pruthi S
J Womens Health (Larchmt); 2014 Oct; 23(10):801-5. PubMed ID: 25268853
[TBL] [Abstract][Full Text] [Related]
16. Estrogen alone in postmenopausal women and breast cancer detection by means of mammography and breast biopsy.
Chlebowski RT; Anderson G; Manson JE; Pettinger M; Yasmeen S; Lane D; Langer RD; Hubbell FA; McTiernan A; Hendrix S; Schenken R; Stefanick ML
J Clin Oncol; 2010 Jun; 28(16):2690-7. PubMed ID: 20439627
[TBL] [Abstract][Full Text] [Related]
17. Estrogen therapy and breast cancer in randomized clinical trials: a narrative review.
Pan K; Lavasani S; Aragaki AK; Chlebowski RT
Menopause; 2022 Sep; 29(9):1086-1092. PubMed ID: 35969882
[TBL] [Abstract][Full Text] [Related]
18. Postmenopausal hormone use and the risk of nephrolithiasis: results from the Women's Health Initiative hormone therapy trials.
Maalouf NM; Sato AH; Welch BJ; Howard BV; Cochrane BB; Sakhaee K; Robbins JA
Arch Intern Med; 2010 Oct; 170(18):1678-85. PubMed ID: 20937929
[TBL] [Abstract][Full Text] [Related]
19. Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects.
Zhao S; Chlebowski RT; Anderson GL; Kuller LH; Manson JE; Gass M; Patterson R; Rohan TE; Lane DS; Beresford SA; Lavasani S; Rossouw JE; Prentice RL
Breast Cancer Res; 2014 Mar; 16(2):R30. PubMed ID: 24670297
[TBL] [Abstract][Full Text] [Related]
20. Menopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy: A Randomized Trial.
Manson JE; Aragaki AK; Bassuk SS; Chlebowski RT; Anderson GL; Rossouw JE; Howard BV; Thomson CA; Stefanick ML; Kaunitz AM; Crandall CJ; Eaton CB; Henderson VW; Liu S; Luo J; Rohan T; Shadyab AH; Wells G; Wactawski-Wende J; Prentice RL;
Ann Intern Med; 2019 Sep; 171(6):406-414. PubMed ID: 31499528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]